Note: This webinar took place on the 20-June-2017. You can find a video recording and the presentations used during the webinar below.
A very important result from the EUPATI project was the development, broad consultation and final release of guidances on the best approach to interaction of patients with pharmaceutical industry-led medicines R&D, regulatory authorities, ethics committees and HTA agencies. This webinar focuses on the Guidance on Patient involvement in regulatory processes.
- David Haerry, EATG
- Wolf See, Bayer
- Cordula Landgraf, SwissMedic
- Giulio Corbelli, EATG